Skip to main content

Breadcrumb

  1. Home
  2. News & Publications
  3. Publications
  4. ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia

ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia

 Stable expression of ERBB2 mutants in NIH 3T3 fibroblasts exhibited spontaneous foci formation in monolayers independent of cell plating density

Joshi et al. (2020) Leukemia. CC BY 4.0

Joshi SK, Keck JM, Eide CA, Bottomly D, Traer E, Tyner JW, McWeeney SK, Tognon CE, Druker BJ.
Leukemia
PROGRAM:
CTD²
Last Updated: